Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial - Williams, JG; Alam, MF; Alrubaiy, L (The Lancet Gastroenterol Hepatol, 2016)
et al.